Di seguito sono riportate le informazioni acquisite su FRESENIUS SE & CO. KGAA, che non è ancora inclusa nel nostro perimetro di ricerca.

Per richiedere una valutazione di questa azienda e l'inserimento nel Ranking OpenCorporation o se hai dati ulteriori, diversi e più aggiornati di quanto pubblicato in questa scheda aziendale OpenCorporation, scrivi a info@opencorporation.org così che il nostro team possa tenerne conto.

Aggiornato il 22 marzo 2021

Descrizione attività
(disponibile solo in inglese)

Manufacture of medical and dental instruments and supplies (NACE2 3250)

This company, formerly known as Fresenius AG, is engaged in providing a broad range of innovative healthcare products and services. It was founded in 1912 by Dr. Eduard Fresenius under the name Dr. E. Fresenius. The registered head office of the company is located in Bad Homburg, Germany. The company operates through its five business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Fresenius Biotech. The Fresenius Medical Care unit specialises in supplying medical equipment and devices for hemodialysis, acute dialysis, peritoneal dialysis, dialysis care, spectra laboratories, liver support therapy, and therapeutical apheresis. Its Fresenius Kabi business offers a variety of products for infusion therapy and clinical nutrition, including oncology drugs, anaesthetics, analgesics, and anti-infectives; syringe pumps and volumetric pumps; and cell separators, autotransfusion devices, and blood bag systems. The Fresenius Helios segment is involved in the management and operation of acute care hospitals, and post-acute care hospitals in Germany. The Fresenius Vamed business provides a comprehensive range of services for hospitals and other health care facilities, including feasibility studies, operational and organisational planning, it planning, medical-technical maintenance, building technology planning, and turn-key projects. The Fresenius Biotech unit is dedicated to delivering innovative therapeutics to patients with serious illnesses that have a high degree of unmet need. The company employs more than 130,000 people. It also operates in Italy, Spain, France, United Kingdom, Austria, Switzerland, Netherlands, Belgium, Norway, Sweden, Poland, Canada, Mexico, Brazil, China, Korea, India, South Africa, Portugal and the Czech Republic.

  • FRESENIUS SE & CO. KGAA

  • Germany (DE)
  • Tipo di azienda: Corporate
  • Impresa controllante: N/D
  • Amministratore Delegato (CEO): Dr. Gerd Edgar Krick
  • Compenso Amministratore Delegato: N/D
  • Sito web: www.fresenius.de

Parametri finanziari

Numero di dipendenti

N/D
294.134
276.750
273.249

Fatturato 1

N/D
35,869
34,78
34,279

EBIT 1

N/D
4,631
5,251
4,589

EBITDA 1

N/D
6,188
6,681
6,026

1 numeri espressi in milioni

  • RepRisk indicator (ultimo mese):  40

Dialogo sociale

  • Transnational Corporate Agreement (TCA): N/D
  • Global Framework Agreement (GFA): N/D
  • Societas Europaea (SE):
  • Bangladesh Accord: N/D

Comitati Aziendali Europei

Standard e certificazioni

  • Global Compact: N/D
  • CDP (Carbon Disclosure Project): N/D
  • Modern Slavery Statement: N/D
  • Transparency Index: N/D
  • SA8000 Social Accountability: N/D
  • Bilancio Integrato: N/D
  • ISO26000: N/D
  • Linee Guida Ocse:
  • Social Development Goals (SDGs): N/D

Certificazione Global Reporting Initiative

  • Global Reporting Initiative standards: N/D
  • Global Reporting Initiative GRI G4: N/D

Altre dichiarative aziendali

  • Responsabilità sociale d'impresa:
    N/D
  • Accessibilità: N/D

Policy

  • Policy sulla formazione: N/D
  • Policy a tutela del diritto alla salute e alla sicurezza nei luoghi di lavoro dove opera l'azienda: N/D
  • Policy a tutela del diritto alla salute e alla sicurezza nei luoghi di lavoro lungo filiera: N/D
  • Policy sulla diversità: N/D

Dichiarazioni universali

Dichiarazioni e trattati riconosciuti dal paese in cui l'azienda ha la sede legale

  • Dichiarazione universale dei Diritti Umani:
  • Convenzione europea dei diritti dell'uomo (CEDU):
  • Carta dei Diritti Fondamentali dei Lavoratori CDFL (Carta di Strasburgo 1989):
  • Carta dei diritti fondamentali dell'Unione Europea CDF UE (Carta di Nizza 2000):
  • Trattato sul funzionamento dell'Unione europea TFUE:
  • Sede legale in un Paese OCSE:
  • ILO C029 - Forced Labour Convention, 1930 (No. 29):
  • ILO C087 - Freedom of Association and Protection of the Right to Organise Convention, 1948 (No. 87):
  • ILO C098 - Right to Organise and Collective Bargaining Convention, 1949 (No. 98):
  • ILO C100 - Equal Remuneration Convention, 1951 (No. 100):
  • ILO C105 - Abolition of Forced Labour Convention, 1957 (No. 105):
  • ILO C111 - Discrimination (Employment and Occupation) Convention, 1958 (No. 111):
  • ILO C138 - Minimum Age Convention, 1973 (No. 138):
  • ILO C182 - Worst Forms of Child Labour Convention, 1999 (No. 182):

Direttive applicate alle sedi nella UE 27

  • D. 80/987/EEC:
  • D. 89/391/EEC:
  • D. 98/59/EC:
  • D. 2000/43/EC:
  • D. 2000/78/EC:
  • D. 2001/23/EC:
  • D. 2001/86/EC del Consiglio:
  • D. 2002/14/EC:
  • D. 2002/73/EC:
  • D. 2003/72/EC del Consiglio:
  • D. 2005/56/EC del PE e del Consiglio:
  • D. 2009/38/EC:
  • D. 2004/25/EC:
  • D. 2011/35/EU:

Presenza nei principali ranking

  • Global 100 Most Sustainable Corporations: N/D
  • Global CSR Rep Trak 100: N/D
  • BrandZ Top 100 Most Valuable US Brands: N/D
  • The Worlds Best Multinational Workplaces: N/D
  • The Gartner Supply Chain Top 25: N/D
  • The Worlds Most Innovative Companies: N/D
  • The Diversity Inc Top 50 Companies: N/D
  • Best Global Websites: N/D
  • Green Ranking Global Top 500: N/D
  • Green Ranking Global Top 100: N/D